Development and characterization of highly selective target-sensitive liposomes for the delivery of streptokinase: in vitro/in vivo studies
Streptokinase is one of the most commonly used thrombolytic agents for the treatment of
thromboembolism. Short half-life of the streptokinase requires administration of higher dose …
thromboembolism. Short half-life of the streptokinase requires administration of higher dose …
Development and characterization of highly selective target-sensitive liposomes for the delivery of streptokinase: in vitro/in vivo studies
B Vaidya, MK Nayak, D Dash, GP Agrawal, SP Vyas - Drug delivery, 2016 - iro.uiowa.edu
Streptokinase is one of the most commonly used thrombolytic agents for the treatment of
thromboembolism. Short half-life of the streptokinase requires administration of higher dose …
thromboembolism. Short half-life of the streptokinase requires administration of higher dose …
[PDF][PDF] Development and characterization of highly selective target-sensitive liposomes for the delivery of streptokinase: in vitro/in vivo studies
B Vaidya, MK Nayak, D Dash, GP Agrawal, SP Vyas - researchgate.net
Streptokinase is one of the most commonly used thrombolytic agents for the treatment of
thromboembolism. Short half-life of the streptokinase requires administration of higher dose …
thromboembolism. Short half-life of the streptokinase requires administration of higher dose …
Development and characterization of highly selective target-sensitive liposomes for the delivery of streptokinase: in vitro/in vivo studies
B Vaidya, MK Nayak, D Dash, GP Agrawal… - Drug …, 2016 - pubmed.ncbi.nlm.nih.gov
Streptokinase is one of the most commonly used thrombolytic agents for the treatment of
thromboembolism. Short half-life of the streptokinase requires administration of higher dose …
thromboembolism. Short half-life of the streptokinase requires administration of higher dose …
Development and characterization of highly selective target-sensitive liposomes for the delivery of streptokinase: in vitro/in vivo studies.
B Vaidya, MK Nayak, D Dash, GP Agrawal, SP Vyas - Drug Delivery, 2014 - europepmc.org
Streptokinase is one of the most commonly used thrombolytic agents for the treatment of
thromboembolism. Short half-life of the streptokinase requires administration of higher dose …
thromboembolism. Short half-life of the streptokinase requires administration of higher dose …
Development and characterization of highly selective target-sensitive liposomes for the delivery of streptokinase: in vitro/in vivo studies
B Vaidya, MK Nayak, D Dash, GP Agrawal… - Drug Delivery, 2016 - repository.ias.ac.in
Streptokinase is one of the most commonly used thrombolytic agents for the treatment of
thromboembolism. Short half-life of the streptokinase requires administration of higher dose …
thromboembolism. Short half-life of the streptokinase requires administration of higher dose …
Development and characterization of highly selective target-sensitive liposomes for the delivery of streptokinase: in vitro/in vivo studies
B Vaidya, MK Nayak, D Dash, GP Agrawal, SP Vyas - Drug delivery, 2016 - iro.uiowa.edu
Streptokinase is one of the most commonly used thrombolytic agents for the treatment of
thromboembolism. Short half-life of the streptokinase requires administration of higher dose …
thromboembolism. Short half-life of the streptokinase requires administration of higher dose …